Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding.

Saved in:
Bibliographic Details
Title: Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding.
Authors: Faries D; Real-World Access and Analytics, Eli Lilly & Company, Indianapolis, USA., Gao C; Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA., Zhang X; Medical Affairs Biostatistics, CSL Behring, King of Prussia, USA., Hazlett C; Departments of Statistics & Data Science and Political Science, University of California at Los Angeles, Los Angeles, USA., Stamey J; Department of Statistical Science, Baylor University, Waco, USA., Yang S; Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA., Ding P; Department of Statistics, University of California Berkeley, Berkeley, USA., Shan M; Real-World Access and Analytics, Eli Lilly & Company, Indianapolis, USA., Sheffield K; Value, Economics, and Outcomes, Eli Lilly & Company, Indianapolis, USA., Dreyer N; Dreyer Strategies, USA.
Source: Pharmaceutical statistics [Pharm Stat] 2025 Mar-Apr; Vol. 24 (2), pp. e2457. Date of Electronic Publication: 2024 Dec 04.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1539-1612
DOI:10.1002/pst.2457